Package 0078-0697-61

{"route": ["ORAL"], "spl_id": "b8a1cc48-9aaf-486a-9305-090acccb5c02", "openfda": {"unii": ["4U07F515LG"], "rxcui": ["825421", "825425", "825427", "825429", "884617", "884619", "1245001", "1245003", "1859498", "1859501", "2058980", "2058981"], "spl_set_id": ["7714a0ed-34bb-46e6-a0a5-b363908b22c2"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CARTON in 1 KIT (0078-0697-61)  / 30 PACKET in 1 CARTON (0078-0697-23)  / 1 POWDER, FOR SUSPENSION in 1 PACKET (0078-0697-19)", "package_ndc": "0078-0697-61", "marketing_start_date": "20200327"}], "brand_name": "PROMACTA", "product_id": "0078-0697_b8a1cc48-9aaf-486a-9305-090acccb5c02", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "0078-0697", "generic_name": "eltrombopag olamine", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PROMACTA", "active_ingredients": [{"name": "ELTROMBOPAG OLAMINE", "strength": "25 mg/1"}], "application_number": "NDA207027", "marketing_category": "NDA", "marketing_start_date": "20180927", "listing_expiration_date": "20261231"}